Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
spinoff
Fierce Biotech
BioVie plans $20M IPO for spinout developing liver disease drug
BioVie is eyeing a $19.7 million IPO for a spinout focused on bringing a new formulation of an approved low blood pressure drug to market.
James Waldron
Mar 17, 2026 5:18am
Mallinckrodt, Endo become Keenova following generics spinoff
Nov 11, 2025 9:54am
Fierce Biotech
CSL to lose up to 15% of staff, cut R&D costs, spin out vaccines
Aug 19, 2025 7:06am
Pfizer, Alzheimer's blood test, Samsung—Fierce Pharma Asia
May 23, 2025 9:00am
CDMO Samsung Biologics telegraphs spinoff of biosim unit
May 22, 2025 11:41am
AmplifyBio shutters amid tough cell and gene therapy market
Apr 7, 2025 10:38am
